The focus needs to be on growing the company not on the stock price. If the company executes its business plan successfully the stock price will follow.
I don't think cancelling is an option at this point, unless you want a lawsuit on top of everything else. Although, the deal definitely is hard to understand now that we've seen the impact Covid has had on their business and cash flow. Was it really the right time to make an acquisition given the environment they find themselves in?
I don't know. I'm gonna have to watch that web presentation again where they discussed the deal.
We need insiders to start stepping in here with some significant buying.
There was much hoopla about the deal yet not a bit of return months in. Unless there is some sort of deal in the works to justify it I agree. What is going on with this company is akin to malpractice. This is the second time that they have gotten in to a deal that is either weak or lacking due diligence. Remember Building IQ?
News 
Market Data 
Discover 
